Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.
By D. Packer, R. Kowal, K. Wheelan, J. Irwin, J. Champagne, P. Guerra, M. Dubuc, V. Reddy, Linda Nelson, R. Holcomb and 2 more. Journal of the American College of Cardiology, 2013
909 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/997a80bf0106061ea5bcf4c06c261e01e05c2fde
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design (2012, methodology): “Among these eight studies, two have been performed under the auspices of the FDA as part of an Investigational Device Exemption (IDE) approval process [279, 505].”
- 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017, background): “Studies have shown a higher risk of PN injury associated with the smaller 23-mm balloon compared with the larger 28-mm balloon with more proximal energy application.(462,482) The smaller balloon is potentially advanced further within the PV, causing distortion of the anatomy, creating a higher susce”